Plain-English translation of NCT06182683 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using two advanced imaging tools together—optical coherence tomography (OCT) and fractional flow reserve (FFR)—during heart stent placement leads to better outcomes than the standard imaging method used today. Both tools help doctors see inside your coronary arteries and measure blood flow to guide exactly where and how to place the stent. The trial will compare patients who receive stents guided by this newer two-tool approach with patients who receive stents using traditional imaging alone.
Doctors want to know if combining these two advanced imaging techniques gives patients better long-term results after stent placement. Right now, no one has studied whether using both tools together works better than the traditional method, so this trial aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new two-tool guided stent placement or the standard imaging-guided approach. During the procedure, your doctors will use either the traditional method or the advanced imaging tools to guide stent placement in your coronary arteries. After the procedure, you will be followed to track how well your heart is doing and whether the stent is working properly.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
South Korea